Tumor-Microenvironment-Activatable Nanoparticle Mediating Immunogene Therapy and M2 Macrophage-Targeted Inhibitor for Synergistic Cancer Immunotherapy-Reference-Cited by-同舟云学术

Tumor-Microenvironment-Activatable Nanoparticle Mediating Immunogene Therapy and M2 Macrophage-Targeted Inhibitor for Synergistic Cancer Immunotherapy

Published:2024-01-22 Issue:4 Volume:18 Page:3295-3312
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Hu Yuzhu¹²,Nie Wen²,Lyu Liang¹,Zhang Xifeng¹,Wang Wanyu¹,Zhang Yunchu¹,He Shi¹,Guo Anjie¹,Liu Fei³,Wang Bilan⁴,Qian Zhiyong¹^ORCID,Gao Xiang¹^ORCID

Affiliation:

1. Department of Neurosurgery and Institute of Neurosurgery, State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, PR China

2. Department of Radiation Oncology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, PR China

3. Department of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China

4. Department of Pharmacy, West China Second University Hospital of Sichuan University, Chengdu 610041, P. R. China

Funder

West China Hospital, Sichuan University

Health Commission of Sichuan Province

Science and Technology Department of Sichuan Province

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.3c10037

Reference51 articles.